Birth Control

Patients are seeing misinformation and disinformation online; here’s how to spot the difference and respond with clarity.

HPV self-collection, asynchronous telehealth abortion studies, young people and permanent contraception access, clinician confidence gaps in abortion navigation, shifting contraceptive preferences postpartum

An 18-year-old (she/her) started a combined hormonal contraceptive pill (COC) three months ago, prescribed by her primary care provider. She’s been taking a pill with 0.15 mg levonorgestrel/30 mcg EE. She’s now following up with you because she’s been feeling moodier since starting the pill. She’s not totally sure if the pill is to blame, but says it’s affecting her quality of life and she’s interested in talking about other options.

A 24 year-old patient (she/her) comes into clinic. During the visit, she expresses interest in starting on a hormonal implant. She was diagnosed with systemic lupus erythematosus (SLE) six months ago and is currently taking hydroxychloroquine. The patient reports no history of low platelets, but she doesn’t know her antibody status at the time of the visit. She reports no other medical conditions or current medications.

A patient in your clinic is requesting to have an LNG-IUD placed today. You note that their last menstrual period (LMP) started 10 days ago, and when asked about recent unprotected vaginal intercourse, they report they last had sex three days ago.

Apply now to Bedsider's new video initiative, #Ask Bedsider

Practical strategies for adjusting combined oral contraceptive formulations to manage side effects and improve patient experiences

US-MEC 2024 update, NuvaRing for adenomyosis, COCs & psychotropic meds, abortion bans & maternal health, adolescent abortion info